Researchers are developing new vaccines for Bundibugyo Ebola strains in the Democratic Republic of the Congo.
9 reports, 5 independent
Updated Jul 30
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 9
- Developments
- 2
- Repetition
- 89%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Researchers are developing new vaccines for Bundibugyo Ebola strains in the Democratic Republic of the Congo.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- A university researcher is leading a team investigating the current Ebola outbreak and collaborating on a viral-vector vaccine.Sub-event
New vaccine development is underway for Bundibugyo Ebola strains in the DRC.1 source
Keep exploring
Part of
An Ebola outbreak is ongoing in the DRC, coinciding with conflict involving Rwanda-backed M23 groups and preparations for future vaccine deployment.Also in this story
- Laboratories in South Kivu ran out of necessary supplies on June 10, 2026.
- M23 forces are conducting large-scale operations in Goma, gaining control of key areas, and carrying out operations in Bukavu.
The entities involved
- DRC
-
University of Oxford
collegiate research university in Oxford, England
- Mathews Mtumbuka's career journey includes studying engineering at MUBAS, working for Airtel in Malawi, and later gaining experience with Shell Oil in Scotland before pursuing a PhD at the University of Oxford.
- A study focused on high blood pressure in England was conducted using data from the Our Future Health programme.
Related events
Coverage
Newest first; wire copies grouped- umn.edu
- forbes.com
- chinadaily.com.cnDR Congo Ebola cases top 3,000
- africanews.com
- sierraleonetimes.com